Survival benefit of resection of locally advanced pancreatic cancer following upfront FOLFIRINOX versus FOLFIRINOX only treatment: a multicenter propensity score-matched analysis. (2021) - Brada, L.; Daamen, L.; Magermans, L.; Walma, M.; Latifi, D.; van Dam, R.; de Hingh, I.; Liem, M.; de Meijer, V.; Patijn, G.; Festen, S.; Stommel, M.; et al.